Ibrance

Discussion in 'Pfizer' started by anonymous, Aug 1, 2015 at 6:56 PM.

  1. anonymous

    anonymous Guest

    We are going to get this drug up here in Canada very soon. Easy sell or tough sell? Data looks good (at least that's what the company is telling us).
     

  2. anonymous

    anonymous Guest

    sure is easy to pretend you're a rep working in Canada. Easier to doubt it with all the dirtbag troll posts looking on these threads for any specifics in the immunology market. Before we feed you free specifics, you share first. Who are you collecting for? Competitions brand team directly? of one of those third party pharma/bio pharma competitive market, business market research firms? You are asking some pretty specific market info. We do need to protect our own pay checks and are not obligated to make you easy money. If you have selfish reasons to profit off of what we know, we should at least get some specifics on you.